/QLINEA.ST
QLINEA.ST Stock - Q-linea AB (publ)
Healthcare|Medical - Instruments & SuppliesSTO
$22.36+1.64%
+$0.36 (+1.64%) • Dec 23
53
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.2
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.91
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $24.60
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for QLINEA.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$22.14 – $22.58
TARGET (TP)$25.71
STOP LOSS$20.57
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.72
52W High$985.00
52W Low$20.79
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.36M | $4.44M | $12.79M | $9.34M | $243,000 |
| Gross Profit | $-11,113,000 | $995,000 | $-21,380,000 | $-25,029,000 | $-32,020,000 |
| Gross Margin | -470.5% | 22.4% | -167.2% | -268.1% | -13177.0% |
| Operating Income | $-213,641,000 | $-230,587,000 | $-262,247,000 | $-233,550,000 | $-221,543,000 |
| Net Income | $-216,871,000 | $-229,366,000 | $-275,770,000 | $-233,183,000 | $-220,191,000 |
| Net Margin | -9181.7% | -5165.9% | -2156.5% | -2497.9% | -90613.6% |
| EPS | $-0.26 | $-3.48 | $-9.44 | $-8.26 | $-8.70 |
Company Overview
Q-linea AB (publ) engages in the development of instruments and consumables for infection diagnostics in Sweden. It offers inventive systems for in vitro diagnostics systems for infectious diseases. The company's lead product candidate is ASTar, an antibiotic susceptibility testing system used for positive blood cultures. It develops and delivers solutions for healthcare providers. Q-linea AB (publ) was incorporated in 2008 and is headquartered in Uppsala, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
QLINEA.STBeat Rate
23%
Last 13 quarters
Avg Surprise
-94.9%
EPS vs Estimate
Beats / Misses
3/10
Last 12 quarters
Latest EPS
$-6.12
Q4 2025
EPS Surprise History
Q1 24
-105.0%
$-0.82vs$-0.40
Q2 24
-20.0%
$-0.48vs$-0.40
Q3 24
-40.0%
$-0.56vs$-0.40
Q4 24
+10.0%
$-0.36vs$-0.40
Q1 25
-1025.0%
$-0.45vs$-0.04
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 13, 2026 | — | — | — | — |
Q1 2026 | Feb 26, 2026 | — | — | — | — |
Q4 2025 | Oct 20, 2025 | — | $-6.12 | — | — |
Q3 2025 | Jul 10, 2025 | — | $-9.13 | — | — |
Q2 2025 | Apr 14, 2025 | — | $-0.02 | — | — |
Q1 2025 | Feb 25, 2025 | $-0.04 | $-0.45 | -1025.0% | ✗ MISS |
Q4 2024 | Nov 5, 2024 | $-0.40 | $-0.36 | +10.0% | ✓ BEAT |
Q3 2024 | Jul 11, 2024 | $-0.40 | $-0.56 | -40.0% | ✗ MISS |
Q2 2024 | May 31, 2024 | $-0.40 | $-0.48 | -20.0% | ✗ MISS |
Q1 2024 | Feb 27, 2024 | $-0.40 | $-0.82 | -105.0% | ✗ MISS |
Q4 2023 | Nov 2, 2023 | $-0.50 | $-0.56 | -12.0% | ✗ MISS |
Q3 2023 | Jul 13, 2023 | $-2.60 | $-2.23 | +14.2% | ✓ BEAT |
Q2 2023 | May 4, 2023 | $-2.05 | $-2.10 | -2.4% | ✗ MISS |
Q1 2023 | Feb 16, 2023 | $-1.80 | $-2.18 | -21.1% | ✗ MISS |
Q4 2022 | Oct 31, 2022 | $-1.90 | $-2.03 | -6.8% | ✗ MISS |
Q3 2022 | Jul 14, 2022 | $-2.20 | $-2.53 | -15.0% | ✗ MISS |
Q2 2022 | May 5, 2022 | $-2.12 | $-2.64 | -24.5% | ✗ MISS |
Q1 2022 | Feb 17, 2022 | $-2.11 | $-1.81 | +14.4% | ✓ BEAT |
Q4 2021 | Nov 4, 2021 | — | $-1.68 | — | — |
Q3 2021 | Jul 15, 2021 | — | $-2.47 | — | — |
Latest News
Loading news...
Frequently Asked Questions about QLINEA.ST
What is QLINEA.ST's current stock price?
Q-linea AB (publ) (QLINEA.ST) is currently trading at $22.36 per share. The stock has moved +1.64% today.
What is the analyst price target for QLINEA.ST?
No analyst price targets are currently available for this stock.
What sector is Q-linea AB (publ) in?
Q-linea AB (publ) operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the STO exchange.
What is QLINEA.ST's market cap?
Q-linea AB (publ) has a market capitalization of $0.14 billion, making it a small-cap company.
Does QLINEA.ST pay dividends?
No, Q-linea AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACUC.ST
AcuCort AB
$0.57
Mkt Cap: $0.1B
ALZ.ST
Alzinova AB (publ)
$0.82
Mkt Cap: $0.1B
BRAIN.ST
BrainCool AB (publ)
$0.58
Mkt Cap: $0.1B
ERMA.ST
Enorama Pharma AB (publ)
$2.30
Mkt Cap: $0.2B
INTEG-B.ST
Integrum AB (publ)
$10.06
Mkt Cap: $0.2B
IZAFE-B.ST
iZafe Group AB (publ)
$0.47
Mkt Cap: $0.1B
KLAR.ST
Klaria Pharma Holding AB (publ.)
$0.61
Mkt Cap: $0.2B
NEOLA.ST
Neola Medical AB (publ)
$1.11
Mkt Cap: $0.1B
NOSA.ST
Nosa Plugs AB
$0.62
Mkt Cap: $0.2B
SENZA.ST
SenzaGen AB
$5.98
Mkt Cap: $0.2B
Explore stocks similar to QLINEA.ST for comparison